Sources:
1) Asvold BO., “Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study.” Arch Intern Med. 2008 Apr 28;168(8):855-60.
2) Asvold BO., “The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study” Eur J Endocrinol February 1, 2007 156 181-186.
3) Baisier, W. V., “Thyroid Insufficiency. Is Thyroxine the Only Valuable Drug?” Journal of Nutritional & Environmental Medicine. (2001), 11, 159-166.
4) Carvalho, D. P., “Thyroid peroxidase activity is inhibited by amino acids” Brazilian Journal of Medical and Biological Research. 2000 Mar;33(3):355-61.
5) Fukusen N.,”Inhibition of chymase activity by phosphoglycerides.” Archives of Biochemistry and Biophysics. 1985 Feb 15;237(1):118-23.
6) Chopra I.J., “Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′-triiodothyronine in sera of patients with nonthyroidal illnesses.” The journal of clinical endocrinology and metabolism. 1985 Apr;60(4):666-72.
7) Tabachnick M., “Effect of long-chain fatty acids on the binding of thyroxine and triiodothyronine to human thyroxine-binding globulin.” Biochimica et Biophysica Acta. 1986 Apr 11;881(2):292-6.
8) Wiersinga W.M., “Inhibition of nuclear T3 binding by fatty acids.” Metabolism. 1988 Oct;37(10):996-1002.
9) Rafael J. “The effect of essential fatty acid deficiency on basal respiration and function of liver mitochondria in rats.” The journal of nutrition. 1984 Feb;114(2):255-62.
10) Fery, F., “Hormonal and metabolic changes induced by an isocaloric isoproteinic ketogenic diet in healthy subjects.” Diabetes and Metabolism. 1982 Dec;8(4):299-305.
11) Orzechowska-Pawiłojć, A., “The influence of thyroid hormones on homocysteine and atherosclerotic vascular disease” Endokrynol Pol. 2005 Mar-Apr;56(2):194-202.
12) Ramsden C.E., “Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis.” BMJ. 2013 Feb 4;346:e8707.
13) Shering, SG., “Thyroid disorders and breast cancer.” Eur J Cancer Prev. 1996 Dec;5(6):504-6.
14) Ratcliffe, J. G.,”Thyroid function in lung cancer” Br Med J. Jan 28, 1978; 1(6107): 210–212.
15) Turken, O.,”Breast cancer in association with thyroid disorders.” Breast Cancer Res. 2003;5(5):R110-3. Epub 2003 Jun 5.
16)Linos, A. “Does coffee consumption protect against thyroid disease?” Acta chirurgica Scandinavica. 1989 Jun-Jul;155(6-7):317-20.
17) Petrek, J.A., “The inhibitory effect of caffeine on hormone-induced rat breast cancer” Cancer. 1985 Oct 15;56(8):1977-81.
18) Nakanishi, N. “Effects of coffee consumption against the development of liver dysfunction: a 4-year follow-up study of middle-aged Japanese male office workers.” Industrial Health. 2000 Jan;38(1):99-102.
19) Freedman, Neal D. “Association of Coffee Drinking with Total and Cause-Specific Mortality” New England Journal of Medicine. 2012; 366:1891-1904.
20) Nauman A., “The Effect of Adrenaline Pretreatment on the In Vitro Generation of 3,5,3′-Triiodothyronine and 3,3′,5′-Triiodothyronine (Reverse T3) in Rat Liver Preparation” Hormone and metabolic research. 1984 Sep;16(9):471-4.
21) Heyma P., “Glucocorticoids decrease in conversion of thyroxine into 3, 5, 3′-tri-iodothyronine by isolated rat renal tubules.” Clin Sci (Lond). 1982 Feb;62(2):215-20.
22) Laugero K.D., “A new perspective on glucocorticoid feedback: relation to stress, carbohydrate feeding and feeling better.” J Neuroendocrinol. 2001 Sep;13(9):827-35.
23) Konno N., “Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan.”The Journal of Clinical Endocrinology & Metabolism. 1994 Feb;78(2):393-7.
24) Zois C., “High prevalence of autoimmune thyroiditis in schoolchildren after elimination of iodine deficiency in northwestern Greece.” Thyroid. 2003 May;13(5):485-9.
25) Harach H.R., “Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis.” Acta Endocrinol (Copenh). 1985 Jan;108(1):55-60.
26) Wémeau JL., “Hypothyroidism related to excess iodine.” Presse Médicale. 2002 Oct 26;31(35):1670-5.
27) Ruwhof C., “Iodine and thyroid autoimmune disease in animal models.” Thyroid. 2001 May;11(5):427-36.
28) Himmelstein DU., “Medical bankruptcy in the United States, 2007: results of a national study.” Am J Med. 2009 Aug;122(8):741-6.